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Abstract 
BACKGROUND: Over the past two decades, more thorough investigations for hepatitis E virus (HEV) infection 
have been done in the world. Reports from Southeast European countries have increased. 
AIM: The current article presents a critical analysis of all studies for HEV in Bulgaria. 
MATERIAL AND METHODS: A literature search was done using available medical databases. We analysed the 
literature in PubMed databases and Bulgarian medical databases for English and Bulgarian languages sources. 
Preference was given to the sources published within the past 24 years (January 1995 – September 2018). 
RESULTS: Two thousand two hundred and fifty-seven blood serums were tested for the analysed period (1995 – 
2018), and 13.1% of them were positive for acute HEV (Mean ± SD: 20.38 ± 25.77%; 95% CI: 1.29 – 39.47%). 
The following subtypes were established in the country – HEV Subtype 3e, HEV Subtype 3f, HEV Subtype 3c, 
HEV Subtype 3i, HEV Subtype 3hi and HEV Subtype 1. 
CONCLUSION: We hope that the National Health Organizations will take adequate and timely measures to 
increase the knowledge and research for HEV among Bulgarian citizens. 
 
 
 
 
 
 
 
 
 
 
Introduction 
 
Hepatitis E virus (HEV) infection is an 
infectious disease which thorough investigation has 
realised over the past twenty years [1] [2]. First 
studies of HEV were from the late 1970s and the early 
1980s [3], [4]. In Bulgaria, the first human cases were 
reported by Teoharov et al., in 1995 [5]. The infection 
has been investigated thoroughly in the country since 
2008 [6], [7]. Some Bulgarian authors presented data 
for HEV infection among Bulgarian patients [8], [9]. 
However, there are still many unknown questions 
about this infection in our country.  
The aim of this study is a critical analysis of all 
available articles for HEV infection in Bulgaria.  
Materials and Methods  
 
Study Design  
A literature search was done using available 
medical databases. We analysed the literature in 
PubMed databases and Bulgarian medical databases 
for English and Bulgarian languages sources using 
the following keywords ”Hepatitis E virus” AND 
“Bulgaria” AND “HEV” AND “Hepatitis E virus 
infection” AND “HEV infection”. No age restriction was 
observed. All studies were written in the English or 
Bulgarian language. The critical analysis included 
original articles, brief reports and case series. The 
critical analysis excluded articles with missing data for 
the number of investigated individuals, case reports 
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and letters to the editor. Preference was given to the 
sources published within the past 24 years (January 
1995 – September 2018).  
 
Ethics Statement  
The study was performed by the principles of 
the Declaration of Helsinki. Participation in the study 
was fully voluntary and anonymous and written 
informed consent was obtained from each person 
before the medical examination.  
 
Statistical Analysis  
The results obtained from the majority of 
studies do not allow detailed statistical analysis. 
Therefore, basic statistical indicators such as 
confidence interval (CI), standard deviation (SD), etc. 
were applied. Statistical analysis was performed by 
Excel 2007 (Microsoft, Redmond, Washington, USA) 
and SPSS Statistics 19.0 (IBM Corp., Armonk, New 
York, USA). A P-value < 0.05 was considered 
statistically significant.  
 
 
Results  
 
We found 23 papers (PubMed databases – 5; 
Bulgarian medical databases – 18). Seven articles 
fulfilled the inclusion and exclusion criteria and were 
included in the final data analysis (Table 1) [5], [8], [9], 
[10], [11], [12], [13]. All articles described hospitalised 
patients with clinical presentation of acute HEV 
infection. Two thousand two hundred and fifty-seven 
blood serums were tested for the analysed period 
(1995 – 2018), and 13.1% of them were positive for 
acute HEV (Mean ± SD: 20.38 ± 25.77%; 95% CI: 
1.29 – 39.47%). Individuals have been tested for anti-
HEV IgG and/or anti-HEV IgM. The following subtypes 
were established in the country – HEV Subtype 3e 
(GenBank accession number 77A 2012-BG, 2588 
2011-BG, 2308 2011-BG, et al), HEV Subtype 3f 
(GenBank access. num. 762 2011-BG, 855 2011-BG, 
688A 2010-BG, et al.,), HEV Subtype 3c (GenBank 
access. num. ISS75 Plov 2014, ISS100 Paz 2014, 
ISS2 Sof 2013, et al.,), HEV Subtype 3i (GenBank 
access. num. 1785 2011-BG, 905 2012-BG), HEV 
Subtype 3hi (GenBank access. num. ISS62 Paz 
2014), and HEV Subtype 1 (GenBank access. num. 
ISS78 Haskovo – travel Afghanistan 2014) [9], [13]. In 
Bulgaria HEV infection affected predominately male 
gender (male/female – 80.0/20.0%). The mean age of 
HEV-positive people varied between 50.7 ± 23.0 
years (95% CI: 32.26 – 69.06) for Sofia district [8], 
and 53.6 ± 14.0 years (95% CI: 45.66 – 61.49) for 
Plovdiv district [10].  
 
Table 1: Studies on acute hepatitis E virus infection in Bulgaria  
First author and 
reference 
Year of 
Publication 
Methodology 
Target 
group 
Diagnostics 
Investigated, 
(n) 
HEV 
positive, 
(n) 
Teoharov et al. 
[5] 
1995 Retrospective Hospitalized ELISA 53 4 
Dikov et al. [8] 2012 Retrospective Hospitalized ELISA 117 6 
Teoharov et al. 
[9] 
2014 Retrospective Hospitalized 
ELISA 
HEV RNA 
741 67 
Petrov et al. 
[10] 
2015 Retrospective Hospitalized ELISA 112 12 
Baymakova et 
al. [11] 
2016 Retrospective Hospitalized ELISA 806 20 
Stoykova et al. 
[12] 
2017 Retrospective Hospitalized ELISA 325 111 
Bruni et al. [13] 2018 Retrospective Hospitalized 
ELISA 
HEV RNA 
103 76 
 
 
 
Discussion  
 
HEV infection more frequently affects male 
than female (61-69%) [14]. Similar data were found in 
Bulgarian studies for HEV gender distribution 
(male/female – 80.0/20.0%). But opposite data were 
reported from Romania (male/female – 40/60%) [15], 
and Turkey (21.4/78.6%) [16].  
The highest incidence of HEV infection is 
observed in people over fifty years [14]. Similar data 
are reported from Romania (28% HEV-positive in the 
age group of 45-65 years) [15], Turkey (50.9 ± 16.8 
years) [16], and Albania (35% HEV-positive in the age 
group over 50 years) [17]. In Bulgaria, HEV infection 
occurs mainly in people over 50 years of age.  
Up to now, there are only two Bulgarian 
studies for HEV phylogenetic analysis of human 
samples [9], [13]. The studies established HEV 
Subtype 3e, HEV Subtype 3f, HEV Subtype 3c, HEV 
Subtype 3i, HEV Subtype 3hi and HEV Subtype 1 [9], 
[13]. It is known that HEV Subtype 3e occurs mainly in 
swine, HEV Subtype 3f is human subtype, and HEV 
Subtype 3i is mainly wild boar subtype. The 
established HEV Subtype 3e in Bulgaria is close to 
the reference sequence AB248520 Japan 3e. The 
established HEV Subtype 3f showed high similarity 
with reference sequence EU495148 France Hu 3f. 
The third found HEV Subtype 3i in Bulgaria is familiar 
to reference sequence FJ705359 Germany wild boar 
3i. These results indicate that the virus might have an 
autochthonous character in Bulgaria with zoonotic 
potential and main reservoirs as domestic pigs and 
wild boars.  
In Bulgaria, HEV infection is poorly known 
and diagnosed. The realised human studies are 
focused on the clinical manifestations and 
characteristics of acute clinical form. There are many 
uncertain things about HEV infection in Bulgaria. First, 
a basic problem has no established HEV case 
definition in Bulgaria. Second, has not enough 
investigations on HEV RNA among Bulgarian patients. 
Third, there is no licensed diagnostic laboratory for 
hepatitis E sequencing (HEV RNA analysis). Fourthly, 
there are no morbidity registers for HEV in Bulgaria. 
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Therefore, in some areas of the country, it is not 
known what is the real prevalence of HEV among the 
population. Fifth, the mortality of HEV is unknown 
among Bulgarian citizens. Sixthly, HEV 
seroprevalence is unknown for risk groups (HIV-
positive patients, immunocompromised persons, 
transplanted patients and pregnant women). Seventh, 
animals’ investigations are limited in the country. 
There is one study for HEV seropositivity among pigs 
in industrial farms in Bulgaria [18]. The results from 
this project found 40% HEV-positive pigs [18].  
There are some reasons for those missing 
information and knowledge for HEV in Bulgaria. First, 
there is a lack of coordination and collaboration 
between scientific societies of infectious diseases 
specialists, microbiologists, virologists and 
gastroenterologists. Second, the researches in the 
country are poorly financed. Third, the Ministry of 
Health does not record the incidence and mortality of 
HEV infection in Bulgaria. Fourthly, National Health 
Authorities do not conduct a screening programme for 
blood and blood products for hepatitis E virus. Fifth, 
the veterinary services in the country do not search for 
HEV infection routinely in animals (domestic pigs, wild 
boars, bears, dogs, cats, etc.). Sixthly, lack of 
efficiency of some hospitals. Seventh, poor diagnostic 
capacity of some hospital laboratories. Eighth, poorly 
trained medical staff is seeking, recognising and 
investigating HEV infection.  
In conclusion, the combination of these facts 
leads to the national position of insufficient evidence 
of HEV infection in our country. The notified 
weaknesses could be revised, and the local situations 
could be improved. We hope that the National Health 
Organizations will take adequate and timely measures 
to increase the knowledge and research for HEV 
among Bulgarian citizens.  
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